Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma JOURNAL OF GASTROINTESTINAL SURGERY Valero-Elizondo, J., Kim, Y., Prescott, J. D., Margonis, G. A., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Glenn, J. A., Hatzaras, I., Shenoy, R., Phay, J. E., Keplinger, K., Fields, R. C., Jin, L. X., Weber, S. M., Salem, A., Sicklick, J. K., Gad, S., Yopp, A. C., Mansour, J. C., Duh, Q., Seiser, N., Solorzano, C. C., Kiernan, C. M., Votanopoulos, K. I., Levine, E. A., Poultsides, G. A., Pawlik, T. M. 2015; 19 (12): 2154-2161

Abstract

Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis. Given the lack of data on readmission after resection of ACC, the objective of the current study was to define the incidence of readmission, as well as identify risk factors associated with readmission among patients with ACC who underwent surgical resection.Two hundred nine patients who underwent resection of ACC between January 1993 and December 2014 at 1 of 13 major centers in the USA were identified. Demographic and clinicopathological data were collected and analyzed relative to readmission.Median patient age was 52 years, and 62 % of the patients were female. Median tumor size was 12 cm, and the majority of patients had an American Society of Anesthesiologists (ASA) class of 3-4 (n?=?85, 56 %). The overall incidence of readmission within 90 days from surgery was 18 % (n?=?38). Factors associated with readmission included high ASA class (odds ratio (OR), 4.88 (95 % confidence interval (CI), 1.75-13.61); P?=?0.002), metastatic disease on presentation (OR, 2.98 (95 % CI, 1.37-6.46); P?=?0.006), EBL (>700 mL: OR, 2.75 (95 % CI, 1.16-6.51); P?=?0.02), complication (OR, 1.91 (95 % CI, 1.20-3.05); P?=?0.007), and prolonged length of stay (LOS; =9 days: OR, 4.12 (95 % CI, 1.88-9.01); P?

View details for DOI 10.1007/s11605-015-2917-x

View details for PubMedID 26286367

View details for PubMedCentralID PMC4951184